Judith V. Hobrath

1.7k total citations
34 papers, 1.3k citations indexed

About

Judith V. Hobrath is a scholar working on Molecular Biology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Judith V. Hobrath has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Infectious Diseases and 7 papers in Pharmacology. Recurrent topics in Judith V. Hobrath's work include Tuberculosis Research and Epidemiology (8 papers), Biochemical and Molecular Research (6 papers) and Cancer therapeutics and mechanisms (6 papers). Judith V. Hobrath is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), Biochemical and Molecular Research (6 papers) and Cancer therapeutics and mechanisms (6 papers). Judith V. Hobrath collaborates with scholars based in United States, United Kingdom and Australia. Judith V. Hobrath's co-authors include Robert C. Reynolds, Subramaniam Ananthan, Lynn Rasmussen, E. Lucile White, Melinda Sosa, John A. Secrist, Cecil D. Kwong, Clinton Maddox, Joseph A. Maddry and Robert C. Goldman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biochemistry.

In The Last Decade

Judith V. Hobrath

34 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judith V. Hobrath United States 20 608 423 226 219 211 34 1.3k
Aditi Singh India 20 787 1.3× 273 0.6× 61 0.3× 146 0.7× 296 1.4× 86 1.3k
Gwendolyn A. Marriner United States 9 352 0.6× 226 0.5× 105 0.5× 55 0.3× 171 0.8× 11 1.1k
Wibke E. Diederich Germany 22 842 1.4× 139 0.3× 247 1.1× 184 0.8× 93 0.4× 55 1.6k
Minos–Timotheos Matsoukas Greece 19 775 1.3× 96 0.2× 208 0.9× 231 1.1× 50 0.2× 64 1.3k
Cédric Logé France 20 402 0.7× 299 0.7× 557 2.5× 62 0.3× 235 1.1× 46 1.2k
Bei Tong China 24 797 1.3× 248 0.6× 52 0.2× 46 0.2× 157 0.7× 48 1.6k
Ben S. Sidders United Kingdom 18 850 1.4× 512 1.2× 43 0.2× 71 0.3× 443 2.1× 29 1.6k
Byung Woo Han South Korea 24 1.2k 1.9× 79 0.2× 271 1.2× 63 0.3× 126 0.6× 99 1.8k
Ilene M. Reardon United States 24 1.3k 2.2× 424 1.0× 83 0.4× 110 0.5× 71 0.3× 35 2.3k

Countries citing papers authored by Judith V. Hobrath

Since Specialization
Citations

This map shows the geographic impact of Judith V. Hobrath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith V. Hobrath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith V. Hobrath more than expected).

Fields of papers citing papers by Judith V. Hobrath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith V. Hobrath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith V. Hobrath. The network helps show where Judith V. Hobrath may publish in the future.

Co-authorship network of co-authors of Judith V. Hobrath

This figure shows the co-authorship network connecting the top 25 collaborators of Judith V. Hobrath. A scholar is included among the top collaborators of Judith V. Hobrath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith V. Hobrath. Judith V. Hobrath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Słomiński, Andrzej, Tae‐Kang Kim, Radomir M. Slominski, et al.. (2023). Melatonin and Its Metabolites Can Serve as Agonists on the Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor Gamma. International Journal of Molecular Sciences. 24(20). 15496–15496. 45 indexed citations
2.
Salio, Mariolina, Wael Awad, Natacha Veerapen, et al.. (2020). Ligand-dependent downregulation of MR1 cell surface expression. Proceedings of the National Academy of Sciences. 117(19). 10465–10475. 49 indexed citations
3.
Torrie, Leah S., David A. Robinson, Michael G. Thomas, et al.. (2020). Discovery of an Allosteric Binding Site in Kinetoplastid Methionyl-tRNA Synthetase. ACS Infectious Diseases. 6(5). 1044–1057. 9 indexed citations
4.
Veerapen, Natacha, et al.. (2020). Chemical insights into the search for MAIT cells activators. Molecular Immunology. 129. 114–120. 4 indexed citations
5.
Simithy, Johayra, Judith V. Hobrath, Jnanendra Rath, et al.. (2018). Slow-Binding Inhibition of Mycobacterium tuberculosis Shikimate Kinase by Manzamine Alkaloids. Biochemistry. 57(32). 4923–4933. 26 indexed citations
6.
Słomiński, Andrzej, Tae‐Kang Kim, Judith V. Hobrath, et al.. (2017). Characterization of a new pathway that activates lumisterol in vivo to biologically active hydroxylumisterols. Scientific Reports. 7(1). 11434–11434. 72 indexed citations
7.
Mathew, Bini, Judith V. Hobrath, Wenyan Lü, Yonghe Li, & Robert C. Reynolds. (2017). Synthesis and preliminary assessment of the anticancer and Wnt/β-catenin inhibitory activity of small amide libraries of fenamates and profens. Medicinal Chemistry Research. 26(11). 3038–3045. 18 indexed citations
8.
Słomiński, Andrzej, Tae‐Kang Kim, Judith V. Hobrath, et al.. (2016). Endogenously produced nonclassical vitamin D hydroxy-metabolites act as “biased” agonists on VDR and inverse agonists on RORα and RORγ. The Journal of Steroid Biochemistry and Molecular Biology. 173. 42–56. 124 indexed citations
9.
Owusu, Benjamin Y., Namita Bansal, Larry J. Ross, et al.. (2015). Design and Synthesis of Nonpeptide Inhibitors of Hepatocyte Growth Factor Activation. ACS Medicinal Chemistry Letters. 7(2). 177–181. 18 indexed citations
10.
Gurcha, Sudagar S., Veeraraghavan Usha, Jonathan A. G. Cox, et al.. (2014). Biochemical and Structural Characterization of Mycobacterial Aspartyl-tRNA Synthetase AspS, a Promising TB Drug Target. PLoS ONE. 9(11). e113568–e113568. 26 indexed citations
11.
Ekins, Sean, Joel S. Freundlich, Judith V. Hobrath, E. Lucile White, & Robert C. Reynolds. (2013). Combining Computational Methods for Hit to Lead Optimization in Mycobacterium Tuberculosis Drug Discovery. Pharmaceutical Research. 31(2). 414–435. 42 indexed citations
12.
Usha, Veeraraghavan, Judith V. Hobrath, Sudagar S. Gurcha, Robert C. Reynolds, & Gurdyal S. Besra. (2012). Identification of Novel Mt-Guab2 Inhibitor Series Active against M. tuberculosis. PLoS ONE. 7(3). e33886–e33886. 22 indexed citations
13.
14.
Reynolds, Robert C., Subramaniam Ananthan, Judith V. Hobrath, et al.. (2011). High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv. Tuberculosis. 92(1). 72–83. 83 indexed citations
15.
Maddry, Joseph A., Xi Chen, Colleen B. Jonsson, et al.. (2010). Discovery of Novel Benzoquinazolinones and Thiazoloimidazoles, Inhibitors of Influenza H5N1 and H1N1 Viruses, from a Cell-Based High-Throughput Screen. SLAS DISCOVERY. 16(1). 73–81. 26 indexed citations
16.
Manuvakhova, Marina, Misti C. White, Subramaniam Ananthan, et al.. (2010). Identification of novel small molecule activators of nuclear factor‐κb with neuroprotective action via high‐throughput screening. Journal of Neuroscience Research. 89(1). 58–72. 16 indexed citations
17.
Zhang, Lisha, Krister Wennerberg, Yujie Li, et al.. (2010). A High‐Throughput Screen for Chemical Inhibitors of Exocytic Transport in Yeast. ChemBioChem. 11(9). 1291–1301. 6 indexed citations
18.
Li, Qianjun, Clinton Maddox, Lynn Rasmussen, Judith V. Hobrath, & Lucile E. White. (2009). Assay development and high-throughput antiviral drug screening against Bluetongue virus. Antiviral Research. 83(3). 267–273. 38 indexed citations
19.
Ananthan, Subramaniam, Wei Zhang, & Judith V. Hobrath. (2009). Recent Advances in Structure-Based Virtual Screening of G-Protein Coupled Receptors. The AAPS Journal. 11(1). 178–185. 17 indexed citations
20.
Maddry, Joseph A., Subramaniam Ananthan, Robert C. Goldman, et al.. (2009). Antituberculosis activity of the molecular libraries screening center network library. Tuberculosis. 89(5). 354–363. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aditi Singh Breakdown of academic impact, for papers by Gwendolyn A. Marriner Breakdown of academic impact, for papers by Wibke E. Diederich Breakdown of academic impact, for papers by Minos–Timotheos Matsoukas Breakdown of academic impact, for papers by Cédric Logé Breakdown of academic impact, for papers by Bei Tong Breakdown of academic impact, for papers by Ben S. Sidders Breakdown of academic impact, for papers by Byung Woo Han Breakdown of academic impact, for papers by Ilene M. Reardon
Rankless by CCL
2026